Molecular Testing in Metastatic Gastric/GEJ Cancer
3 Visualizzazioni
• 06/30/23
0
0
Incorporare
administrator
Iscritti
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti